{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:12:51Z","timestamp":1794334371048,"version":"4.9.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11312-6","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:59:11Z","timestamp":1764593951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sepsis-associated immunosuppression: mechanistic Insights, Biomarkers, and therapeutic perspectives"],"prefix":"10.1007","volume":"53","author":[{"given":"Mehmet Akif","family":"Ovali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevval","family":"Percin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"11312_CR1","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1001\/jama.1992.03490240060037","volume":"268","author":"RC Bone","year":"1992","unstructured":"Bone RC (1992) Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452\u20133455. https:\/\/doi.org\/10.1001\/jama.1992.03490240060037","journal-title":"JAMA"},{"key":"11312_CR2","doi-asserted-by":"publisher","first-page":"1577105","DOI":"10.3389\/fimmu.2025.1577105","volume":"16","author":"X Gao","year":"2025","unstructured":"Gao X, Cai S, Li X, Wu G (2025) Sepsis-induced immunosuppression: mechanisms, biomarkers and immunotherapy. Front Immunol 16:1577105. https:\/\/doi.org\/10.3389\/fimmu.2025.1577105","journal-title":"Front Immunol"},{"key":"11312_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29:71\u2013109. https:\/\/doi.org\/10.1146\/annurev-immunol-031210-101312","journal-title":"Annu Rev Immunol"},{"key":"11312_CR4","doi-asserted-by":"publisher","first-page":"543622","DOI":"10.3389\/fimmu.2020.01043","volume":"11","author":"MA McBride","year":"2020","unstructured":"McBride MA, Owen AM, Stothers CL, Hernandez A, Luan L, Burelbach KR, Patil TK, Bohannon JK, Sherwood ER, Patil NK (2020) The metabolic basis of immune dysfunction following sepsis and trauma. Front Immunol 11:543622. https:\/\/doi.org\/10.3389\/fimmu.2020.01043","journal-title":"Front Immunol"},{"key":"11312_CR5","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s00134-010-1965-7","volume":"36","author":"JC Schefold","year":"2010","unstructured":"Schefold JC (2010) Measurement of monocytic HLA-DR (mHLA-DR) expression in patients with severe sepsis and septic shock: assessment of immune organ failure. Intensive Care Med 36:1810\u20131812. https:\/\/doi.org\/10.1007\/s00134-010-1965-7","journal-title":"Intensive Care Med"},{"key":"11312_CR6","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/cc10112","volume":"15","author":"C Guignant","year":"2011","unstructured":"Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Ch\u00e9ron A, Allaouchiche B, Gueyffier F, Ayala A, Monneret G, Venet F (2011) Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care 15:R99. https:\/\/doi.org\/10.1186\/cc10112","journal-title":"Crit Care"},{"key":"11312_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fmolb.2019.00085","volume":"6","author":"SF Fitzpatrick","year":"2019","unstructured":"Fitzpatrick SF (2019) Immunometabolism and sepsis: a role for HIF? Front Mol Biosci 6:85. https:\/\/doi.org\/10.3389\/fmolb.2019.00085","journal-title":"Front Mol Biosci"},{"key":"11312_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40779-022-00430-y","volume":"9","author":"F Pei","year":"2022","unstructured":"Pei F, Yao RQ, Ren C, Bahrami S, Billiar TR, Chaudry IH, Chen DC, Chen XL, Cui N, Fang XM, Kang Y, Li WQ, Li WX, Liang HP, Lin HY, Liu KX, Lu B, Lu ZQ, Maegele M, Yao YM (2022) Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression. Mil Med Res 9:10. https:\/\/doi.org\/10.1186\/s40779-022-00430-y","journal-title":"Mil Med Res"},{"key":"11312_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00134-006-0204-8","volume":"32","author":"G Monneret","year":"2006","unstructured":"Monneret G, Lepape A, Voirin N, Boh\u00e9 J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P (2006) Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32:1175\u20131183. https:\/\/doi.org\/10.1007\/s00134-006-0204-8","journal-title":"Intensive Care Med"},{"key":"11312_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","volume":"180","author":"C Meisel","year":"2009","unstructured":"Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640\u2013648. https:\/\/doi.org\/10.1164\/rccm.200903-0363OC","journal-title":"Am J Respir Crit Care Med"},{"key":"11312_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s10020-023-00690-x","volume":"29","author":"X Fu","year":"2023","unstructured":"Fu X, Wang Y (2023) Interferon-\u03b3 regulates immunosuppression in septic mice by promoting the Warburg effect through the PI3K\/AKT\/mTOR pathway. Mol Med 29:18. https:\/\/doi.org\/10.1186\/s10020-023-00690-x","journal-title":"Mol Med"},{"key":"11312_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D (2013a) Immunosuppression in sepsis: a novel Understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260\u2013268. https:\/\/doi.org\/10.1016\/S1473-3099(13)70001-X","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"11312_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/S12015-012-9364-9","volume":"8","author":"R Carrero","year":"2012","unstructured":"Carrero R, Cerrada I, Lled\u00f3 E, Dopazo J, Garc\u00eda-Garc\u00eda F, Rubio MP, Trigueros C, Dorronsoro A, Ruiz-Sauri A, Montero JA, Sep\u00falveda P (2012) IL1\u03b2 induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-\u03baB. Stem Cell Rev 8(3):905. https:\/\/doi.org\/10.1007\/S12015-012-9364-9","journal-title":"Stem Cell Rev"},{"key":"11312_CR14","doi-asserted-by":"publisher","first-page":"1130214","DOI":"10.3389\/fimmu.2023.1130214","volume":"14","author":"I Joshi","year":"2023","unstructured":"Joshi I, Carney WP, Rock EP (2023) Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis. Front Immunol 14:1130214. https:\/\/doi.org\/10.3389\/fimmu.2023.1130214","journal-title":"Front Immunol"},{"key":"11312_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4161\/viru.26516","volume":"5","author":"JS Boomer","year":"2014","unstructured":"Boomer JS, Green JM, Hotchkiss RS (2014) The changing immune system in sepsis. Virulence 5:45\u201356. https:\/\/doi.org\/10.4161\/viru.26516","journal-title":"Virulence"},{"key":"11312_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/SLA.0000000000001783","volume":"265","author":"B Mathias","year":"2017","unstructured":"Mathias B, Delmas AL, Ozrazgat-Baslanti T, Vanzant EL, Szpila BE, Mohr AM, Moore FA, Brakenridge SC, Brumback BA, Moldawer LL, Efron PA (2017) Human myeloid-derived suppressor cells are associated with chronic immune suppression after severe sepsis\/septic shock. Ann Surg 265:827\u2013834. https:\/\/doi.org\/10.1097\/SLA.0000000000001783","journal-title":"Ann Surg"},{"key":"11312_CR17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ymthe.2021.12.013","volume":"30","author":"S Huang","year":"2022","unstructured":"Huang S, Liu D, Sun J, Zhang H, Zhang J, Wang Q, Gan L, Qu G, Qiu J, Deng J, Jiang J, Zeng L (2022) Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-\u03baB signaling pathway in CD4 T cells. Mol Ther 30:1227\u20131238. https:\/\/doi.org\/10.1016\/j.ymthe.2021.12.013","journal-title":"Mol Ther"},{"key":"11312_CR18","doi-asserted-by":"publisher","first-page":"e14756","DOI":"10.1097\/MD.0000000000014756","volume":"98","author":"YC Wang","year":"2019","unstructured":"Wang YC, Weng GP, Liu JP, Li L, Cheng QH (2019) Elevated serum IL-37 concentrations in patients with sepsis. Med (Baltim) 98:e14756. https:\/\/doi.org\/10.1097\/MD.0000000000014756","journal-title":"Med (Baltim)"},{"key":"11312_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40635-022-00431-0","volume":"10","author":"IT Schrijver","year":"2022","unstructured":"Schrijver IT, Karakike E, Th\u00e9roude C, Baumgartner P, Harari A, Giamarellos-Bourboulis EJ, Calandra T, Roger T (2022) High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure. Intensive Care Med Exp 10:31. https:\/\/doi.org\/10.1186\/s40635-022-00431-0","journal-title":"Intensive Care Med Exp"},{"key":"11312_CR20","doi-asserted-by":"publisher","first-page":"103345","DOI":"10.1016\/J.ICCN.2022.103345","volume":"75","author":"M Karvouniaris","year":"2023","unstructured":"Karvouniaris M, Papadopoulos D, Koulenti D, Chatzimichail M, Papamichalis P, Ntafoulis N, Valsamaki A, Katsiafylloudis P, Vaitsi E, Oikonomou K, Papapostolou E, Xanthoudaki MA, Papadogoulas A, Palli E, Poulakou G, Komnos A (2023) Impact of secondary sepsis on mortality in adult intensive care unit patients. Intensive Crit Care Nurs 75:103345. https:\/\/doi.org\/10.1016\/J.ICCN.2022.103345","journal-title":"Intensive Crit Care Nurs"},{"key":"11312_CR21","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/infdis\/jiu668","volume":"211","author":"Z Song","year":"2015","unstructured":"Song Z, Zhang J, Zhang X, Li D, Wang H, Xu X, Xu W, Yin Y, Cao J (2015) Interleukin 4 deficiency reverses development of secondary Pseudomonas aeruginosa pneumonia during sepsis-associated immunosuppression. J Infect Dis 211:1616\u20131627. https:\/\/doi.org\/10.1093\/infdis\/jiu668","journal-title":"J Infect Dis"},{"issue":"7","key":"11312_CR22","doi-asserted-by":"publisher","first-page":"e28681","DOI":"10.1097\/MD.0000000000028681","volume":"101","author":"M Xue","year":"2022","unstructured":"Xue M, Xu F, Yang Y, Tao Z, Chen Y, Wang S, Yin J, Min M, Shi D, Yao C, Song Z (2022) Diagnosis of sepsis with inflammatory biomarkers, cytokines, endothelial functional markers from SIRS patients. Med (Baltim) 101(7):e28681. https:\/\/doi.org\/10.1097\/MD.0000000000028681","journal-title":"Med (Baltim)"},{"key":"11312_CR23","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.2147\/IDR.S496568","volume":"17","author":"P Zhang","year":"2024","unstructured":"Zhang P, Liu W, Wang S, Wang Y, Han H (2024) Ferroptosis and its role in the treatment of sepsis-related organ injury: mechanisms and potential therapeutic approaches. Infect Drug Resist 17:5715\u20135727. https:\/\/doi.org\/10.2147\/IDR.S496568","journal-title":"Infect Drug Resist"},{"key":"11312_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13054-016-1233-5","volume":"20","author":"C Arens","year":"2016","unstructured":"Arens C, Bajwa SA, Koch C, Siegler BH, Schneck E, Hecker A, Weiterer S, Lichtenstern C, Weigand MA, Uhle F (2016) Sepsis-induced long-term immune paralysis\u2014results of a descriptive, explorative study. Crit Care 20:124. https:\/\/doi.org\/10.1186\/s13054-016-1233-5","journal-title":"Crit Care"},{"key":"11312_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR (2016) Ferroptosis: death by lipid peroxidation. Trends Cell Biol 26:165\u2013176. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.014","journal-title":"Trends Cell Biol"},{"key":"11312_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41422-020-0301-1","volume":"30","author":"J Saravia","year":"2020","unstructured":"Saravia J, Raynor JL, Chapman NM, Lim SA, Chi H (2020) Signaling networks in immunometabolism. Cell Res 30:328\u2013342. https:\/\/doi.org\/10.1038\/s41422-020-0301-1","journal-title":"Cell Res"},{"key":"11312_CR27","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nature05836","volume":"447","author":"SL Foster","year":"2007","unstructured":"Foster SL, Hargreaves DC, Medzhitov R (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447:972\u2013978. https:\/\/doi.org\/10.1038\/nature05836","journal-title":"Nature"},{"key":"11312_CR28","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1096\/fj.201901900R","volume":"34","author":"K Jin","year":"2020","unstructured":"Jin K, Ma Y, Manrique-Caballero CL, Li H, Emlet DR, Li S, Baty CJ, Wen X, Kim-Campbell N, Frank A, Menchikova EV, Pastor-Soler NM, Hallows KR, Jackson EK, Shiva S, Pinsky MR, Zuckerbraun BS, Kellum JA, G\u00f3mez H (2020) Activation of AMP-activated protein kinase (AMPK) during sepsis\/inflammation improves survival by preserving cellular metabolic fitness. FASEB J 34:7036\u20137057. https:\/\/doi.org\/10.1096\/fj.201901900R","journal-title":"FASEB J"},{"key":"11312_CR29","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL (2016) Sepsis and septic shock. Nat Rev Dis Primers 2:16045. https:\/\/doi.org\/10.1038\/nrdp.2016.45","journal-title":"Nat Rev Dis Primers"},{"key":"11312_CR30","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.ddmod.2011.09.001","volume":"9","author":"SB Hu","year":"2012","unstructured":"Hu SB, Zider A, Deng JC (2012) When host defense goes awry: modeling sepsis-induced immunosuppression. Drug Discov Today Dis Models 9:e33\u2013e38. https:\/\/doi.org\/10.1016\/j.ddmod.2011.09.001","journal-title":"Drug Discov Today Dis Models"},{"key":"11312_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12879-019-3790-0","volume":"19","author":"W Zhang","year":"2019","unstructured":"Zhang W, Zheng Y, Feng X, Chen M, Kang Y (2019) Systemic inflammatory response syndrome in Sepsis-3: a retrospective study. BMC Infect Dis 19:379. https:\/\/doi.org\/10.1186\/s12879-019-3790-0","journal-title":"BMC Infect Dis"},{"key":"11312_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cyto.b.21987","volume":"100","author":"KJ Quadrini","year":"2021","unstructured":"Quadrini KJ, Patti-Diaz L, Maghsoudlou J, Cuomo J, Hedrick MN, McCloskey TW (2021) A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials. Cytometry B Clin Cytom 100:103\u2013114. https:\/\/doi.org\/10.1002\/cyto.b.21987","journal-title":"Cytometry B Clin Cytom"},{"key":"11312_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/cyto.a.23749","volume":"95","author":"G Monneret","year":"2019","unstructured":"Monneret G, Gossez M, Aghaeepour N, Gaudilliere B, Venet F (2019) How clinical flow cytometry rebooted sepsis immunology. Cytometry A 95:431\u2013441. https:\/\/doi.org\/10.1002\/cyto.a.23749","journal-title":"Cytometry A"},{"issue":"4","key":"11312_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1189\/JLB.0509307","volume":"88","author":"CR Romero","year":"2010","unstructured":"Romero CR, Herzig DS, Etogo A, Nunez J, Mahmoudizad R, Fang G, Murphey ED, Toliver-Kinsky T, Sherwood ER (2010) The role of interferon-\u03b3 in the pathogenesis of acute intra-abdominal sepsis. J Leukoc Biol 88(4):725. https:\/\/doi.org\/10.1189\/JLB.0509307","journal-title":"J Leukoc Biol"},{"key":"11312_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann E, Sanz J, Dunn JL, Khan N, Mendon\u00e7a LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier JC, Mailhot-L\u00e9onard F, Ahmed E, Belle J, Besla R, Mazer B, King IL, Nijnik A, Robbins CS, Barreiro LB, Divangahi M (2018) BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172:176\u2013190e19. https:\/\/doi.org\/10.1016\/j.cell.2017.12.031","journal-title":"Cell"},{"key":"11312_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T Van der Poll","year":"2017","unstructured":"Van der Poll T, Van de Veerdonk FL, Scicluna BP, Netea MG (2017) The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 17:407\u2013420. https:\/\/doi.org\/10.1038\/nri.2017.36","journal-title":"Nat Rev Immunol"},{"key":"11312_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000324024","volume":"17","author":"NJ Shubin","year":"2011","unstructured":"Shubin NJ, Monaghan SF, Ayala A (2011) Anti-inflammatory mechanisms of sepsis. Contrib Microbiol 17:108\u2013124. https:\/\/doi.org\/10.1159\/000324024","journal-title":"Contrib Microbiol"},{"key":"11312_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","volume":"27","author":"SB Kovacs","year":"2017","unstructured":"Kovacs SB, Miao EA (2017) Gasdermins: effectors of pyroptosis. Trends Cell Biol 27:673\u2013684. https:\/\/doi.org\/10.1016\/j.tcb.2017.05.005","journal-title":"Trends Cell Biol"},{"key":"11312_CR39","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783\u2013801. https:\/\/doi.org\/10.1016\/j.cell.2006.02.015","journal-title":"Cell"},{"key":"11312_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/ITT.S448691","volume":"13","author":"C Jiang","year":"2024","unstructured":"Jiang C, Chen J, Sun T, Xu J, Zhu H, Chen J (2024) Unveiling dynamic changes and regulatory mechanisms of T cell subsets in sepsis pathogenesis. ImmunoTargets Ther 13:29\u201344. https:\/\/doi.org\/10.2147\/ITT.S448691","journal-title":"ImmunoTargets Ther"},{"key":"11312_CR41","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00134-008-1337-8","volume":"35","author":"F Venet","year":"2009","unstructured":"Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Boh\u00e9 J, Lepape A, Ayala A, Monneret G (2009) Increased Circulating regulatory T cells (CD4\u2009+\u2009CD25\u2009+\u2009CD127\u2013) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35:678\u2013686. https:\/\/doi.org\/10.1007\/s00134-008-1337-8","journal-title":"Intensive Care Med"},{"issue":"4","key":"11312_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/CC11416","volume":"16","author":"G Monneret","year":"2012","unstructured":"Monneret G, Venet F (2012) A rapidly progressing lymphocyte exhaustion after severe sepsis. Crit Care 16(4):140. https:\/\/doi.org\/10.1186\/CC11416","journal-title":"Crit Care"},{"key":"11312_CR43","unstructured":"Al-Khafaji AH et al (2025) Systemic inflammatory response syndrome (SIRS): practice essentials, pathophysiology, etiology. Medscape. https:\/\/emedicine.medscape.com\/article\/168943-overview. Accessed 10 July 2025"},{"key":"11312_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, Der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"11312_CR45","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014\u20131022. https:\/\/doi.org\/10.1038\/ni.1944","journal-title":"Nat Immunol"},{"key":"11312_CR46","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/epidemiologia5030032","volume":"5","author":"L La Via","year":"2024","unstructured":"La Via L, Sangiorgio G, Stefani S, Marino A, Nunnari G, Cocuzza S, La Mantia I, Cacopardo B, Stracquadanio S, Spampinato S, Lavalle S, Maniaci A (2024) The global burden of sepsis and septic shock. Epidemiologia 5:456. https:\/\/doi.org\/10.3390\/epidemiologia5030032","journal-title":"Epidemiologia"},{"key":"11312_CR47","doi-asserted-by":"publisher","first-page":"7943","DOI":"10.4049\/jimmunol.177.11.7943","volume":"177","author":"PO Scumpia","year":"2006","unstructured":"Scumpia PO, Delano MJ, Kelly KM, O\u2019Malley KA, Efron PA, McAuliffe PF, Brusko T, Ungaro R, Barker T, Wynn JL, Atkinson MA, Reeves WH, Salzler MJ, Moldawer LL (2006) Increased natural CD4\u2009+\u2009CD25\u2009+\u2009regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 177:7943\u20137949. https:\/\/doi.org\/10.4049\/jimmunol.177.11.7943","journal-title":"J Immunol"},{"key":"11312_CR48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162\u2013174. https:\/\/doi.org\/10.1038\/nri2506","journal-title":"Nat Rev Immunol"},{"key":"11312_CR49","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cmet.2024.02.013","volume":"36","author":"K Willmann","year":"2024","unstructured":"Willmann K, Moita LF (2024) Physiologic disruption and metabolic reprogramming in infection and sepsis. Cell Metab 36:927\u2013946. https:\/\/doi.org\/10.1016\/j.cmet.2024.02.013","journal-title":"Cell Metab"},{"key":"11312_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.imlet.2004.07.009","volume":"95","author":"G Monneret","year":"2004","unstructured":"Monneret G, Finck ME, Venet F, Debard AL, Boh\u00e9 J, Bienvenu J, Lepape A (2004) The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95:193\u2013198. https:\/\/doi.org\/10.1016\/j.imlet.2004.07.009","journal-title":"Immunol Lett"},{"key":"11312_CR51","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1073\/pnas.0809422106","volume":"106","author":"X Huang","year":"2009","unstructured":"Huang X, Venet F, Wang YL, Lepape A, Yuan Z, Chen Y, Swan R, Kherouf H, Monneret G, Chung CS, Ayala A (2009) PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci USA 106:6303\u20136308. https:\/\/doi.org\/10.1073\/pnas.0809422106","journal-title":"Proc Natl Acad Sci USA"},{"key":"11312_CR52","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.4049\/jimmunol.1400849","volume":"193","author":"A Huang","year":"2014","unstructured":"Huang A, Zhang B, Yan W, Wang B, Wei H, Zhang F, Wu L, Fan K, Guo Y (2014) Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1\u2013induced IL-10. J Immunol 193:5461\u20135469. https:\/\/doi.org\/10.4049\/jimmunol.1400849","journal-title":"J Immunol"},{"key":"11312_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21037\/jmai-24-393","volume":"8","author":"D Mahto","year":"2025","unstructured":"Mahto D, Yadav P, Banavar M, Keany J, Joseph AT, Kilambi S (2025) Development and validation of SXI\u2009+\u2009+\u2009LNM algorithm for sepsis prediction. J Med Artif Intell 8:6. https:\/\/doi.org\/10.21037\/jmai-24-393","journal-title":"J Med Artif Intell"},{"key":"11312_CR54","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D (2013b) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862\u2013874. https:\/\/doi.org\/10.1038\/nri3552","journal-title":"Nat Rev Immunol"},{"key":"11312_CR55","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","volume":"30","author":"SK Biswas","year":"2009","unstructured":"Biswas SK, Lopez-Collazo E (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30:475\u2013487. https:\/\/doi.org\/10.1016\/j.it.2009.07.009","journal-title":"Trends Immunol"},{"key":"11312_CR56","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00134-010-1962-x","volume":"36","author":"C Landelle","year":"2010","unstructured":"Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Boh\u00e9 J, Vanhems P, Monneret G (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859\u20131866. https:\/\/doi.org\/10.1007\/s00134-010-1962-x","journal-title":"Intensive Care Med"},{"key":"11312_CR57","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.3390\/ijms19092738","volume":"19","author":"X Wang","year":"2018","unstructured":"Wang X, Buechler NL, Woodruff AG, Long DL, Zabalawi M, Yoza BK, McCall CE, Vachharajani V (2018) Sirtuins and immuno-metabolism of sepsis. Int J Mol Sci 19:2738. https:\/\/doi.org\/10.3390\/ijms19092738","journal-title":"Int J Mol Sci"},{"key":"11312_CR58","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cmet.2017.06.001","volume":"26","author":"R Stienstra","year":"2017","unstructured":"Stienstra R, Netea-Maier RT, Riksen NP, Joosten LAB, Netea MG (2017) Specific and complex reprogramming of cellular metabolism in myeloid cells during innate immune responses. Cell Metab 26:142\u2013156. https:\/\/doi.org\/10.1016\/j.cmet.2017.06.001","journal-title":"Cell Metab"},{"issue":"4","key":"11312_CR59","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/SHK.0000000000000116","volume":"41","author":"Y Liang","year":"2014","unstructured":"Liang Y, Li X, Zhang X, Li Z, Wang L, Sun Y, Liu Z, Ma X (2014) Elevated levels of plasma TNF-\u03b1 are associated with microvascular endothelial dysfunction in patients with sepsis through activating the NF-\u03baB and p38 mitogen-activated protein kinase in endothelial cells. Shock 41(4):275\u2013281. https:\/\/doi.org\/10.1097\/SHK.0000000000000116","journal-title":"Shock"},{"issue":"8","key":"11312_CR60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/J.IT.2021.06.001","volume":"42","author":"R Karki","year":"2021","unstructured":"Karki R, Kanneganti TD (2021) The \u2018cytokine storm\u2019: molecular mechanisms and therapeutic prospects. Trends Immunol 42(8):681\u2013705. https:\/\/doi.org\/10.1016\/J.IT.2021.06.001","journal-title":"Trends Immunol"},{"key":"11312_CR61","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/cc10059","volume":"15","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Li J, Lou J, Zhou Y, Bo L, Zhu J, Zhu K, Wan X, Cai Z, Deng X (2011) Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit Care 15:R70. https:\/\/doi.org\/10.1186\/cc10059","journal-title":"Crit Care"},{"key":"11312_CR62","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1084\/jem.20140857","volume":"212","author":"M Matsushita","year":"2015","unstructured":"Matsushita M, Freigang S, Schneider C, Conrad M, Bornkamm GW, Kopf M (2015) T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med 212:555\u2013568. https:\/\/doi.org\/10.1084\/jem.20140857","journal-title":"J Exp Med"},{"key":"11312_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","volume":"12","author":"J Quintin","year":"2012","unstructured":"Quintin J, Saeed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, Jacobs L, Jansen T, Kullberg BJ, Wijmenga C, Joosten LAB, Xavier RJ, Van Der Meer JWM, Stunnenberg HG, Netea MG (2012) Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12:223\u2013232. https:\/\/doi.org\/10.1016\/j.chom.2012.06.006","journal-title":"Cell Host Microbe"},{"key":"11312_CR64","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-024-01015-8","volume":"46","author":"AV Ferreira","year":"2024","unstructured":"Ferreira AV, Dom\u00ednguez-Andr\u00e9s J, Merlo Pich LM, Joosten LAB, Netea MG (2024) Metabolic regulation in the induction of trained immunity. Semin Immunopathol 46:283\u2013296. https:\/\/doi.org\/10.1007\/s00281-024-01015-8","journal-title":"Semin Immunopathol"},{"key":"11312_CR65","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00018-022-04490-0","volume":"79","author":"J Liu","year":"2022","unstructured":"Liu J, Zhou G, Wang X, Liu D (2022a) Metabolic reprogramming consequences of sepsis: adaptations and contradictions. Cell Mol Life Sci 79:373. https:\/\/doi.org\/10.1007\/s00018-022-04490-0","journal-title":"Cell Mol Life Sci"},{"key":"11312_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJPATH.2025.05.023","author":"G Sarode","year":"2025","unstructured":"Sarode G, Hsu MF, Haj FG, Barace S, Argemi J, Liu M, Pandita P, Cao S, Shah VH, Gui D, Bataller R, Rachakonda V (2025) IL-6 trans-signaling regulates neutrophilic inflammation in alcohol-associated hepatitis. Am J Pathol. https:\/\/doi.org\/10.1016\/J.AJPATH.2025.05.023","journal-title":"Am J Pathol"},{"key":"11312_CR67","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ccm.2008.06.010","volume":"29","author":"NS Ward","year":"2008","unstructured":"Ward NS, Casserly B, Ayala A (2008) The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med 29:617\u2013625. https:\/\/doi.org\/10.1016\/j.ccm.2008.06.010","journal-title":"Clin Chest Med"},{"key":"11312_CR68","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306:2594\u20132605. https:\/\/doi.org\/10.1001\/jama.2011.1829","journal-title":"JAMA"},{"key":"11312_CR69","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/jcm11010096","volume":"11","author":"F Bidar","year":"2022","unstructured":"Bidar F, Bodinier M, Venet F, Lukaszewicz AC, Brengel-Pesce K, Conti F, Quemeneur L, Leissner P, Tan LK, Textoris J, Rimmel\u00e9 T, Monneret G (2022) Concomitant assessment of monocyte HLA-DR expression and ex vivo TNF-\u03b1 release as markers of adverse outcome after various injuries\u2014insights from the REALISM study. J Clin Med 11:96. https:\/\/doi.org\/10.3390\/jcm11010096","journal-title":"J Clin Med"},{"issue":"4","key":"11312_CR70","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3855\/JIDC.7800","volume":"11","author":"D Wu","year":"2017","unstructured":"Wu D, Zhou S, Hu S, Liu B (2017) Inflammatory responses and histopathological changes in a mouse model of Staphylococcus aureus-induced bloodstream infections. J Infect Dev Ctries 11(4):294\u2013305. https:\/\/doi.org\/10.3855\/JIDC.7800","journal-title":"J Infect Dev Ctries"},{"key":"11312_CR71","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 375:311\u2013322. https:\/\/doi.org\/10.1056\/NEJMoa1603827","journal-title":"N Engl J Med"},{"key":"11312_CR72","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s00134-019-05704-z","volume":"45","author":"RS Hotchkiss","year":"2019","unstructured":"Hotchkiss RS, Colston E, Yende S, Crouser ED, Martin GS, Albertson T, Bartz RR, Brakenridge SC, Delano MJ, Park PK, Donnino MW, Tidswell M, Mayr FB, Angus DC, Coopersmith CM, Moldawer LL, Catlett IM, Girgis IG, Ye J, Grasela DM (2019) Immune checkpoint Inhibition in sepsis: a phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab. Intensive Care Med 45:1360\u20131371. https:\/\/doi.org\/10.1007\/s00134-019-05704-z","journal-title":"Intensive Care Med"},{"key":"11312_CR73","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fimmu.2019.00432","volume":"10","author":"S Tamulyte","year":"2019","unstructured":"Tamulyte S, Kopplin J, Brenner T, Weigand MA, Uhle F (2019) Monocyte HLA-DR assessment by a novel point-of-care device is feasible for early identification of ICU patients with complicated courses-a proof-of-principle study. Front Immunol 10:432. https:\/\/doi.org\/10.3389\/fimmu.2019.00432","journal-title":"Front Immunol"},{"key":"11312_CR74","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/imr.12287","volume":"265","author":"I Jorgensen","year":"2015","unstructured":"Jorgensen I, Miao EA (2015) Pyroptotic cell death defends against intracellular pathogens. Immunol Rev 265:130\u2013142. https:\/\/doi.org\/10.1111\/imr.12287","journal-title":"Immunol Rev"},{"key":"11312_CR75","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40779-022-00422-y","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, Li L, Cao J, Xu F, Zhou Y, Guan CX, Jin SW, Deng J, Fang XM, Jiang JX, Zeng L (2022) Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res 9:56. https:\/\/doi.org\/10.1186\/s40779-022-00422-y","journal-title":"Mil Med Res"},{"key":"11312_CR76","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G, Gkavogianni T, Adami ME, Katsaounou P, Ntaganou M, Kyriakopoulou M, Dimopoulos G, Koutsodimitropoulos I, Velissaris D, Koufargyris P, Karageorgos A, Katrini K, Lekakis V, Koutsoukou A (2020) Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27:992\u20131000e3. https:\/\/doi.org\/10.1016\/j.chom.2020.04.009","journal-title":"Cell Host Microbe"},{"key":"11312_CR77","doi-asserted-by":"publisher","first-page":"651552","DOI":"10.3389\/fmed.2021.651552","volume":"8","author":"M Qu","year":"2021","unstructured":"Qu M, Zhang H, Chen Z, Sun X, Zhu S, Nan K, Chen W, Miao C (2021) The role of ferroptosis in acute respiratory distress syndrome. Front Med 8:651552. https:\/\/doi.org\/10.3389\/fmed.2021.651552","journal-title":"Front Med"},{"key":"11312_CR78","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1128\/IAI.00239-12","volume":"80","author":"L Brudecki","year":"2012","unstructured":"Brudecki L, Ferguson DA, McCall CE, El Gazzar M (2012) Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect Immun 80:2026\u20132034. https:\/\/doi.org\/10.1128\/IAI.00239-12","journal-title":"Infect Immun"},{"key":"11312_CR79","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5847\/wjem.j.1920-8642.2015.01.001","volume":"6","author":"C Cao","year":"2015","unstructured":"Cao C, Ma T, Chai Y, Shou S (2015) The role of regulatory T cells in immune dysfunction during sepsis. World J Emerg Med 6:5\u20139. https:\/\/doi.org\/10.5847\/wjem.j.1920-8642.2015.01.001","journal-title":"World J Emerg Med"},{"key":"11312_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01977","author":"S Caserta","year":"2018","unstructured":"Caserta S, Mengozzi M, Kern F, Newbury SF, Ghezzi P, Llewelyn MJ (2018) Severity of systemic inflammatory response syndrome affects the blood levels of Circulating inflammatory-relevant MicroRNAs. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.01977. 8:1977","journal-title":"Front Immunol"},{"key":"11312_CR81","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.toxicon.2017.10.016","volume":"149","author":"JM Cavaillon","year":"2018","unstructured":"Cavaillon JM (2018) Exotoxins and endotoxins: inducers of inflammatory cytokines. Toxicon 149:45\u201353. https:\/\/doi.org\/10.1016\/j.toxicon.2017.10.016","journal-title":"Toxicon"},{"key":"11312_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc13176","volume":"18","author":"K Chang","year":"2014","unstructured":"Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, Robbins P, Ulbrandt N, Suzich JA, Green J, Patera AC, Blair W, Krishnan S, Hotchkiss R (2014) Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care 18:1\u201315. https:\/\/doi.org\/10.1186\/cc13176","journal-title":"Crit Care"},{"key":"11312_CR83","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ni.3398","volume":"17","author":"SC Cheng","year":"2016","unstructured":"Cheng SC, Scicluna BP, Arts RJW, Gresnigt MS, Lachmandas E, Giamarellos-Bourboulis EJ, Kox M, Manjeri GR, Wagenaars JAL, Cremer OL, Leentjens J, van der Meer AJ, van de Veerdonk FL, Bonten MJ, Schultz MJ, Willems PHGM, Pickkers P, Joosten LAB, van der Poll T, Netea MG (2016) Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol 17:406\u2013413. https:\/\/doi.org\/10.1038\/ni.3398","journal-title":"Nat Immunol"},{"key":"11312_CR84","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature01326","volume":"420","author":"J Cohen","year":"2002","unstructured":"Cohen J (2002) The Immunopathogenesis of sepsis. Nature 420:885\u2013891. https:\/\/doi.org\/10.1038\/nature01326","journal-title":"Nature"},{"key":"11312_CR85","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI82224","volume":"126","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA (2016) Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest 126:23\u201331. https:\/\/doi.org\/10.1172\/JCI82224","journal-title":"J Clin Invest"},{"key":"11312_CR86","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/imr.12499","volume":"274","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA (2016) The immune system\u2019s role in sepsis progression, resolution, and long-term outcome. Immunol Rev 274:330\u2013353. https:\/\/doi.org\/10.1111\/imr.12499","journal-title":"Immunol Rev"},{"key":"11312_CR87","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13054-016-1505-0","volume":"20","author":"AM Drewry","year":"2016","unstructured":"Drewry AM, Ablordeppey EA, Murray ET, Beiter ER, Walton AH, Hall MW, Hotchkiss RS (2016) Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study. Crit Care 20:334. https:\/\/doi.org\/10.1186\/s13054-016-1505-0","journal-title":"Crit Care"},{"issue":"1","key":"11312_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40001-024-02203-W","volume":"29","author":"J Luo","year":"2024","unstructured":"Luo J, Zhang C, Chen D et al (2024) Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression. Eur J Med Res 29(1):1\u201313. https:\/\/doi.org\/10.1186\/S40001-024-02203-W","journal-title":"Eur J Med Res"},{"key":"11312_CR89","doi-asserted-by":"publisher","unstructured":"Payen D, Faivre V, Miatello J et al (2019) Multicentric experience with interferon gamma therapy in sepsis-induced immunosuppression: a case series. BMC Infect Dis 19(1). https:\/\/doi.org\/10.1186\/S12879-019-4526-X","DOI":"10.1186\/S12879-019-4526-X"},{"issue":"4","key":"11312_CR90","doi-asserted-by":"publisher","first-page":"e141245","DOI":"10.1172\/jci.insight.141245","volume":"6","author":"Y Sun","year":"2021","unstructured":"Sun Y, Coopersmith CM, Ford ML (2021) Anti-TIGIT differentially affects sepsis survival in immunologically experienced versus previously Naive hosts. JCI Insight 6(4):e141245. https:\/\/doi.org\/10.1172\/jci.insight.141245","journal-title":"JCI Insight"},{"issue":"1","key":"11312_CR91","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/S10753-023-01897-0","volume":"47","author":"L Yang","year":"2023","unstructured":"Yang L, Gao Q, Li Q, Guo S (2023) PD-L1 Blockade improves survival in sepsis by reversing monocyte dysfunction and immune disorder. Inflammation 47(1):114\u2013128. https:\/\/doi.org\/10.1007\/S10753-023-01897-0","journal-title":"Inflammation"},{"key":"11312_CR92","doi-asserted-by":"publisher","unstructured":"Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmel\u00e9 T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS (2018) Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight 3(5). https:\/\/doi.org\/10.1172\/JCI.INSIGHT.98960","DOI":"10.1172\/JCI.INSIGHT.98960"},{"issue":"11","key":"11312_CR93","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1128\/IAI.00456-10","volume":"78","author":"KR Kasten","year":"2010","unstructured":"Kasten KR, Prakash PS, Unsinger J, Goetzman HS, England LG, Cave CM, Seitz AP, Mazuski CN, Zhou TT, Morre M, Hotchkiss RS, Hildeman DA, Caldwell CC (2010) Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect Immun 78(11):4714\u20134722. https:\/\/doi.org\/10.1128\/IAI.00456-10","journal-title":"Infect Immun"},{"key":"11312_CR94","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/J.INTIMP.2018.05.031","volume":"62","author":"X Kong","year":"2018","unstructured":"Kong X, Zhang J, Huo J, Wang L, Guo L, Liu Y, He T, Sun Z, Chen X, Hou Z, Yang X, Tian Y, Sun S, Chen F, Liu Y (2018) A systematic investigation on animal models of cyclosporine A combined with Escherichia coli to simulate the immunosuppressive status of sepsis patients before onset. Int Immunopharmacol 62:67\u201376. https:\/\/doi.org\/10.1016\/J.INTIMP.2018.05.031","journal-title":"Int Immunopharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11312-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11312-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11312-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:59:12Z","timestamp":1764593952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11312-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11312"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11312-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is a review study, and no ethical approval is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"148"}}